-
1 Comment
SpineGuard SA is currently in a long term downtrend where the price is trading 5.6% below its 200 day moving average.
From a valuation standpoint, the stock is 98.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.4.
Based on the above factors, SpineGuard SA gets an overall score of 1/5.
| Exchange | PA |
|---|---|
| CurrencyCode | EUR |
| ISIN | FR0011464452 |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | 8M |
|---|---|
| PE Ratio | None |
| Target Price | 0.8 |
| Beta | 0.6 |
| Dividend Yield | None |
SpineGuard SA provides designs, develops, and markets medical devices in the United States, Europe, Latin America, Asia Pacific, and the Middle East. The company offers PediGuard drilling instruments comprising straight, curved, cannulated, PsiFGuard, and threaded PediGuard products. It also provides DSG Connect app that provides surgeons real time visualization of the audio feedback from the DSG Technology during pedicle drillings to ease the signal interpretation. The company's products are used in orthopedic robots and dental implantology. SpineGuard SA was incorporated in 2009 and is headquartered in Vincennes, France.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for ALSGD.PA using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026